This finding is challenging, since two of the crucial points in the insulin treatment of patients with T1D are the dawn phenomena (reflex on fasting blood glucose) and the later-afternoon hyperglycemia (reflex on pre-dinner blood glucose). This evidence concerns the gene INS and Hyperglycemia.